These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8472505)

  • 1. Circadian variations in platelet aggregability in non insulin dependent diabetes patients (NIDDM).
    Spanò GM; La Mancusa R; Pettirossi G; Pulcinelli FM; Gazzaninga PP; Cordova C
    Clin Ter; 1993 Jan; 142(1):19-22. PubMed ID: 8472505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
    Nakajima S; Noguchi T; Taka T; Ueda T; Kaizu K; Fukamizu M; Fujita S; Tabuchi M; Yamamoto J
    Platelets; 2000 Dec; 11(8):459-66. PubMed ID: 11177445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Altered circadian rhythm of platelet aggregation in patients on longterm hemodialysis].
    Rydzewski A; Małyszko J; Borawski J; Pawlak D; Adamcewicz K; Buczko W; Myśliwiec M
    Przegl Lek; 1997; 54(3):167-70. PubMed ID: 9297192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered circadian blood pressure rhythm and progression of diabetic nephropathy in non-insulin dependent diabetes mellitus subjects: an average three year follow-up study.
    Nakano S; Ishii T; Kitazawa M; Kigoshi T; Uchida K; Morimoto S
    J Investig Med; 1996 Jun; 44(5):247-53. PubMed ID: 8763975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics.
    Coppola L; Misso L; Giugliano D; Torella R; Passariello N; Tirelli A
    Diabete Metab; 1984 Jan; 10(1):31-5. PubMed ID: 6724099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circadian rhythm of platelet aggregation induced by adrenaline and collagen in man].
    Nubile G; D'Alonzo L; Consoli A; Moutzouridis G; Sensi S
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):947-50. PubMed ID: 7126369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
    Serebruany V; Malinin A; Pokov A; Arora U; Atar D; Angiolillo D
    Thromb Res; 2007; 119(2):175-81. PubMed ID: 16546241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study.
    Andrews NP; Gralnick HR; Merryman P; Vail M; Quyyumi AA
    J Am Coll Cardiol; 1996 Dec; 28(7):1789-95. PubMed ID: 8962568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correction of the disturbed coagulation circadian rhythm in patients with type 1 diabetes mellitus treated by aspirin chronotherapy].
    Zaslavskaia RM; Tulemisov EU
    Klin Med (Mosk); 2008; 86(10):17-23. PubMed ID: 19069453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morning rise of systolic blood pressure (by 24-hour ambulatory monitoring) and platelet aggregability in essential hypertension patients].
    Oshchepkova EV; Lazareva NV; Filatova LV; Zelveian PA; Arabidze GG
    Ter Arkh; 2000; 72(4):47-51. PubMed ID: 10833799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct beneficial effect of insulin on blood rheological disorders in the microcirculation.
    Mantskava M; Pargalava N; McHedlishvili G
    Clin Hemorheol Microcirc; 2004; 30(3-4):431-3. PubMed ID: 15258380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
    Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
    Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
    Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
    Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
    Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation in obese and diabetic subjects: association with leptin level.
    Sugiyama C; Ishizawa M; Kajita K; Morita H; Uno Y; Matsubara K; Matsumoto M; Ikeda T; Ishizuka T
    Platelets; 2007 Mar; 18(2):128-34. PubMed ID: 17365861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
    Angiolillo DJ; Shoemaker SB; Desai B; Yuan H; Charlton RK; Bernardo E; Zenni MM; Guzman LA; Bass TA; Costa MA
    Circulation; 2007 Feb; 115(6):708-16. PubMed ID: 17261652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.